P3 Health Partners raises ~$89.5M in private placement of common stock and warrants

P3 Health Partners Inc.

Issued ~69.2M shares, ~59.9M warrants, ~10.8M pre-funded warrants at ~$1.12/unit for institutions, ~$1.19 for employees/consultants.
CPF affiliates purchase ~$71M of the offering, including ~52.8M shares, ~10.8M pre-funded warrants, ~47.6M warrants.
Closing expected April 6, 2023; registration statement to be filed within 30 days post-closing.
CPF gets board designation and information rights if ownership >=40%, and standstill until June 30, 2024 limiting ownership to 49.99%.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

P3 Health Partners Inc. entered into Securities Purchase Agreement with the purchasers named therein valued at aggregate gross proceeds of approximately $89.5 million (effective 2023-03-30).

Action: entry
Agreement: equity purchase
Counterparty: the purchasers named therein
Value: aggregate gross proceeds of approximately $89.5 million
Effective: 2023-03-30

Exact text from the filing

On March 30, 2023, P3 Health Partners Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with the purchasers named therein (the “Purchasers”).

View on SEC.gov

84 material agreements filed in the last 30 days. Browse all material agreements →

P3 Health Partners Inc. filing history →

Source: SEC EDGAR

accession 0001104659-23-039658

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.